| Literature DB >> 23125329 |
Brandie Heald1, James Church, Thomas Plesec, Carol A Burke.
Abstract
Hereditary syndromes account for 5% to 10% of cases of colorectal cancer. In clinical practice, patients with these syndromes need to be identified to ensure that they and their families receive genetic counseling and testing and appropriate risk-reducing treatment. Genetic testing can offer a precise diagnosis. It allows for risk stratification and focused management and surveillance.Entities:
Mesh:
Year: 2012 PMID: 23125329 DOI: 10.3949/ccjm.79a.11165
Source DB: PubMed Journal: Cleve Clin J Med ISSN: 0891-1150 Impact factor: 2.321